Market open
$
0.34
Change
+0.02 +6.15%
Volume
Volume 83,773
Mar 21, 2023, 1:02 p.m.
Quotes are delayed by 20 min
Previous close
$ 0.32
$ 0.34
Change
+0.02 +6.15%
Day low
Day high
$0.33
$0.35

52 week low
52 week high
$0.24
$2.43

Market cap
$5.46M
Average volume
167,401
P/E ratio
N/A
Rev. per Employee
$261,037
EPS
-1.04
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on BIOC
-
Biocept stock price target cut to $4 from $5 at Maxim Group
- Tomi Kilgore
-
Biocept swings to Q4 profit on COVID-19 testing
- MarketWatch.com
-
Biocept stock price target raised to $2 from $1 at Maxim Group
- Tomi Kilgore
-
Biocept started at buy with $3 stock price target at Maxim Group
- Tomi Kilgore
-
Biocept initiated as buy with stock price target of $2.50 at Chardan Global Insights
- Ciara Linnane
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For June 2, 2017
- Benzinga.com
-
- Benzinga.com
Other News on BIOC
-
- Edgar Online - (EDG = 10Q, 10K)
-
Agiliti (AGTI) Q3 Earnings Surpass Estimates
- Zacks.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Biocept (BIOC) Investor Presentation - Slideshow
- Seeking Alpha
-
HealthEquity (HQY) Misses Q2 Earnings Estimates
- Zacks.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Biocept reports delay in filing of Q1 report on Form 10-Q
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Biocept taps veteran biotechnology executive as COO
- Seeking Alpha
-
Biocept appoints Samuel Riccitelli as interim president, CEO
- Seeking Alpha
-
Notable earnings after Thursday's close
- Seeking Alpha
- Loading more headlines...
Press Releases on BIOC
-
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Biocept to Explore Strategic Alternatives and Implement Restructuring Plan
- BusinessWire - BZX
-
Biocept Reports Third Quarter 2022 Financial Results
- BusinessWire - BZX
-
Biocept Appoints Financial Executive Quyen Dao-Haddock to its Board of Directors
- BusinessWire - BZX
-
Biocept Reports Second Quarter 2022 Financial Results
- BusinessWire - BZX
-
Biocept to Present at the LD Micro Main Event XV
- BusinessWire - BZX
-
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q
- BusinessWire - BZX
-
Liquid Biopsy Market Share to Witness Steady Rise by 2029
- AmericaNewsHour
-
Biocept Appoints RSM as Independent Auditor
- BusinessWire - BZX
-
Biocept to Hold Business Strategy Conference Call Today
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com